CTMX

CytomX Therapeutics Inc (CTMX)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 373.38M
P/E Ratio
4.94
Revenue (TTM)
$ 147.56M
Volume
0
52W High
$ 3.10
52W Low
$ 0.40
Dividend Yield
0.00%
Beta
2.13

Technicals

50-Day MA
2.4191
200-Day MA
1.313
52 Week High
3.095
52 Week Low
0.4

About CTMX

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Employees
119
Headquarters
South San Francisco, CA
CEO
Dr. Sean A. McCarthy DPHIL

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg